General Electric will no longer seek an IPO for its health-care unit following the sale of its biopharma business, CEO Larry Culp told Bloomberg on Monday.
GE filed confidential paperwork for an IPO of GE Healthcare in December.
The unit is a dominant player in hospital and lab equipment, generating roughly $19 billion in revenue and $3.4 billion in profit last year. It accounted for 15.8 percent of the conglomerate's total sales, and 43.2 percent of its operating profit in 2017.
GE is still exploring options for its imaging business, Culp reportedly also told Bloomberg.
– CNBC's Berkeley Lovelace Jr. contributed to this report.
This story is developing. Please check back for updates.
from Top News & Analysis https://ift.tt/2BTqZqIvia IFTTT
No comments:
Post a Comment